The ATL1 gene gives instructions for making atlastin 1, a protein that helps nerve cells build and maintain their internal membrane network, especially in the long nerves that control leg movement. This gene plays an important role in keeping these nerve pathways working smoothly. When a harmful variant disrupts this job, people may develop an inherited condition called hereditary spastic paraplegia, often with gradually increasing leg stiffness, muscle tightness, and walking difficulties. Symptoms can begin in childhood or adulthood and vary from person to person.
What is a gene?
A gene is a stretch of DNA that holds instructions your cells use to make molecules or regulate processes in the body. Some genes carry the code for proteins, which are the working parts of cells. Others mainly guide when, where, and how strongly certain activities happen. Taken together, genes influence how the body develops and works, and they can shape how you respond to food, stress, or medications. For a more detailed look at this topic, you can learn more in the LearnHub.
Overview
ATL1Gene function
What if the gene works
The ATL1 gene helps shape the endoplasmic reticulum, a cell network that makes and moves proteins and fats. In nerve cells, this supports healthy nerve fibers and communication.
Risk
What if the gene does not work
Variants in the ATL1 gene most often cause hereditary spastic paraplegia with leg stiffness, weakness, and walking problems, often starting in childhood. Milder or more severe variants can influence when symptoms begin and how much movement is affected.
Treatment
What does that mean for your treatment
No ATL1-specific treatment or drug selection is currently established for people with a pathogenic or loss-of-function variant in the ATL1 gene. Care is symptom based, and the ATL1 gene is being studied in early-stage research to better understand nerve cell pathways that may guide future treatments.
Conditions associated with ATL1
Gene function
What if the gene works
Inside your cells, a wide membrane network helps move materials and keep different areas connected. The ATL1 gene supports the shape and linking of this network, called the endoplasmic reticulum. This role is especially important in nerve cells, where the network must extend through very long cell branches.
The ATL1 gene helps the endoplasmic reticulum keep its long, tube-like shape. This network spreads through much of the cell and needs steady connections to work smoothly.
Its protein joins matching endoplasmic reticulum membranes together. This fusion lets separate tubules connect into one continuous network.
In nerve cells, the endoplasmic reticulum extends into long fibers that carry signals. This is how the ATL1 gene helps the endoplasmic reticulum in nerve cells stay linked across long distances.
What is a variant?
A genetic variant is a minor difference in the DNA sequence within a gene. These differences are common and are part of normal human diversity, including variation in appearance, metabolism, and the way the body responds to environmental influences. Many have no noticeable effect and simply represent natural genetic variation. Sometimes, though, a variant changes how a gene works more substantially and can contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Understanding how variants influence the ATL1 gene's function helps explain why some changes have a larger effect than others. Many ATL1 variants alter the atlastin-1 protein so it folds poorly, is less stable, or cannot join and reshape the cell's membrane network (the endoplasmic reticulum), reducing its activity. Milder variants may leave partial function, while more severe variants can cause greater loss of activity and are often linked to earlier onset or more pronounced hereditary spastic paraplegia.
How variants are linked to conditions
Pathogenic variants in the ATL1 gene cause hereditary spastic paraplegia type 3A, the main ATL1 gene condition association recognized in clinical genetics. Most people with an ATL1-related diagnosis develop leg stiffness and walking difficulties, often starting in childhood or early adulthood. Some may have a more limited form mainly affecting the legs, while others have additional nerve symptoms. A smaller number of variants in the ATL1 gene have also been linked to hereditary sensory neuropathy.
A variant is not necessarily a diagnosis
Genetic variants are a routine part of human biology and are common across the general population. Most do not have a direct effect on health and instead reflect natural human diversity. For many genes, having a variant tied to a condition suggests a possible association rather than confirming a diagnosis, especially when multiple genes and environmental factors are involved. In some cases, though, a single well characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For ATL1-related spastic paraplegia, risk is mainly set by whether a disease-causing ATL1 variant runs in the family. Symptoms and severity can vary even within one family, but there is not enough evidence to say that lifestyle changes lower the chance of developing the condition.
Inheritance of ATL1 variants
For families looking into the ATL1 gene inheritance pattern, the best-established pattern is autosomal dominant. This means a parent with an ATL1 variant can pass it to a child, and each pregnancy carries a 50% chance of inheriting that variant. Sons and daughters are affected in the same way because the ATL1 gene is on chromosome 14, not on a sex chromosome. In most families, the variant is passed from one generation to the next.
What does my ATL1 result mean for my family?
For many living with an ATL1 change linked to hereditary spastic paraplegia, close relatives such as parents, brothers, sisters, and children may also carry the same change and could have symptoms, even if these are mild. In families where this runs in a dominant pattern, each child of someone with the change can also inherit it. Family members may want to talk with their care team about whether the result is relevant to them.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a change in the ATL1 gene, testing for ATL1 gene variants uses a blood or saliva sample. A lab reads the DNA sequence and checks for variants. Results may identify a disease causing variant, a benign variant, or a variant of uncertain significance.
When should I consider getting a genetic test?
Genetic testing for the ATL1 gene may be worth considering if someone has ongoing leg stiffness, tight muscles, or walking problems that started in childhood or early adult life, especially if similar symptoms run in the family. An ATL1 result can help explain a form of inherited spastic paraplegia and clarify family risk.
A genetic result is only one part of your health story
Genetic results can provide useful insight, but how much they reveal varies by the condition and the type of variant involved. Over time, many factors shape how the body works, including lifestyle, environment, age, and medical history. In some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is most helpful when considered alongside other parts of care. In other situations, a genetic result may offer a clear answer. In areas like medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. The same medication may work well for one person, seem less helpful for another, or cause more side effects because the body can absorb, break down, or respond to drugs in different ways. These differences are common and can influence how well a treatment works or how sensitive someone is to it.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in a person’s genes affect the way they respond to medicines. By studying links between genes and medications, it helps explain why the same treatment can work differently in different people. For many drugs, genes influence either how strongly the medicine works or how the body handles it. This information can support treatment choices that are better informed and more individualized. More detail on this topic is available in the LearnHub.
Drugs influenced by the ATL1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medicine choice or dose. If you have side effects, poor symptom control, or questions about any treatment, talk with your doctor or pharmacist.
History
ATL1 entered medical genetics through studies of families with hereditary spastic paraplegia, especially those with symptoms beginning in childhood. Initially understood only through visible traits, later recognized as tied to a specific gene, ATL1 was identified in the early 2000s as the cause of SPG3A, one of the better known early onset forms of this condition. This helped explain why some families showed a clear inherited pattern across generations. From these first observations, research expanded steadily, and ATL1 became part of the growing picture of how different genes can lead to similar walking and leg stiffness problems. Its discovery also helped refine classification of hereditary spastic paraplegia into distinct genetic types.